Trade

with

Eli Lilly and Co
(NYSE: LLY)
AdChoices
66.05
+1.70
+2.64%
After Hours :
66.05
0.00
0.00%

Open

64.58

Previous Close

64.35

Volume (Avg)

4.78M (3.92M)

Day's Range

64.40-66.24

52Wk Range

48.88-67.14

Market Cap.

71.90B

Dividend Rate (Yield )

1.96 (3.05%)

Beta

0.43

Shares Outstanding

1.12B

P/E Ratio (EPS)

20.45 (3.14)

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
Industry Drug Manufacturers – Major
Highlights
Analyst Recommendation: Outperform
    • Revenue

    • 23.11B

    • Net Income

    • 4.68B

    • Market Cap.

    • 71.90B

    • Enterprise Value

    • -

    • Net Profit Margin %

    • 16.00

    • PEG (Price/Earnings Growth) Ratio

    • -

    • Beta

    • 0.43

    • Forward P/E

    • 20.20

    • Price/Sales

    • 3.28

    • Price/Book Value

    • 4.00

    • Price/Cash flow

    • 13.83

      • EBITDA

      • 7.50B

      • Return on Capital %

      • 9.94

      • Return on Equity %

      • 20.43

      • Return on Assets %

      • 9.94

      • Book Value/Share

      • 16.10

      • Shares Outstanding

      • 1.12B

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • 0.49 (11/12/2014)

      • Dividend Declaration Date

      • 10/20/2014

      Analyst Recommendation
      10/21/2014
      Outperform
        • 1 Year Price Target

        • 68.33

        • Credit Rating

        • AA

        • Analysts

        • 5

        • EPS Estimate

        • 3.18

        • Cashflow Estimate

        • 3.95

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • -16.80

          • 0.89

          • Net Income

            YTD/YTD (last year)

          • 14.60

          • 7.80

          • Net Income

            Q/Q (last year)

          • -39.20

          • 4.50

          • Sales (Revenue)

            5-Year Annual Average

          • 2.55

          • 6.10

          • Net Income

            5-Year Annual Average

          • -

          • 3.73

          • Dividends

            5-Year Annual Average

          • 0.84

          • 2.17

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 76.43

            • 69.92

            • Pre-Tax Margin

            • 20.07

            • 21.84

            • Net Profit Margin

            • 16.00

            • 18.37

            • Average Gross Margin

              5-Year Annual Average

            • 79.70

            • 71.90

            • Average Pre-Tax Margin

              5-Year Annual Average

            • 24.80

            • 21.92

            • Average Net Profit Margin

              5-Year Annual Average

            • 19.60

            • 903.40B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • 0.29

              • 0.32

              • Current Ratio

              • 1.77

              • 1.92

              • Quick Ratio

              • 1.20

              • 1.31

              • Interest Coverage

              • 28.84

              • 17.64

              • Leverage Ratio

              • 1.95

              • 2.03

              • Book Value/Share

              • 16.10

              • 14.62

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • 20.58

                • 22.99

                • P/E Ratio 5-Year High

                • 21.36

                • 193.96

                • P/E Ratio 5-Year Low

                • 10.19

                • 87.26

                • Price/Sales Ratio

                • 3.29

                • 3.84

                • Price/Book Value

                • 4.02

                • 3.83

                • Price/Cash Flow Ratio

                • 13.83

                • 14.51

                • Key Metrics

                • Company

                • Industry

                  • Return on Equity %

                    (5-Year Average)

                  • 20.43

                    (38.20)

                  • 17.42

                    (18.66)

                  • Return on Assets %

                    (5-Year Average)

                  • 9.94

                    (14.30)

                  • 8.45

                    (8.77)

                  • Return on Capital %

                    (5-Year Average)

                  • 16.03

                    (24.40)

                  • 12.41

                    (13.18)

                  • Income/Employee

                  • 89.44k

                  • 90.07k

                  • Inventory Turnover

                  • 1.69

                  • 2.46

                  • Asset Turnover

                  • 0.62

                  • 0.46

                  Current Historical
                  Financials
                  • Income Statement
                  • Balance Sheet
                  • Cash Flow
                  Operating Income
                  5.37B
                  Operating Margin
                  23.24
                  Total Equity
                  -
                  Retained Earnings
                  -
                  Free Cashflow
                  -
                  Price/Cashflow
                  13.83
                  Ownership

                  Institutional Ownership

                  77.00%

                  Top 10 Institutions

                  39.51%

                  Mutual Fund Ownership

                  34.41%

                  Float

                  87.72%

                  5% / Insider Ownership

                  0.29%

                  Corporate insiders or major stockholders reporting trading activity in the stock.

                  Top Mutual Fund Owners

                  Top Institutional Owners

                  Mutual Fund Name

                  Institution Name

                  • Mutual Fund Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Vanguard PrimeCap Fund

                  •  

                    29,130,000

                  • 0.13

                  • 2.60

                  • Vanguard Health Care Fund

                  •  

                    21,982,700

                  • -3.98

                  • 1.96

                  • Vanguard Total Stock Mkt Idx

                  •  

                    16,431,404

                  • 0.48

                  • 1.47

                  • Vanguard Wellington™

                  •  

                    14,137,500

                  • 0.00

                  • 1.26

                  • Franklin Income Fund

                  •  

                    12,000,000

                  • 0.00

                  • 1.07

                  • Vanguard Five Hundred Index Fund

                  •  

                    10,207,605

                  • 0.04

                  • 0.91

                  • Vanguard Institutional Index Fund

                  •  

                    9,961,028

                  • -1.25

                  • 0.89

                  • SPDR® S&P 500 ETF

                  •  

                    9,679,028

                  • 1.58

                  • 0.86

                  • VA CollegeAmerica Income Fund of America

                  •  

                    8,146,900

                  • 35.78

                  • 0.73

                  • Vanguard Capital Opportunity Fund

                  •  

                    7,288,000

                  • 1.08

                  • 0.65

                  • Institution Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Lilly Endowment Inc

                  •  

                    132,730,804

                  • -0.82%

                  • 11.88

                  • Wellington Management Company, LLP

                  •  

                    65,291,855

                  • -0.07%

                  • 5.83

                  • PRIMECAP Management Company

                  •  

                    57,102,840

                  • -0.05%

                  • 5.10

                  • Vanguard Group, Inc.

                  •  

                    51,960,194

                  • +1.52%

                  • 4.64

                  • State Street Corp

                  •  

                    43,930,182

                  • +3.55%

                  • 3.92

                  • BlackRock Fund Advisors

                  •  

                    32,383,462

                  • +0.31%

                  • 2.89

                  • State Farm Mutual Automobile Ins CO

                  •  

                    19,944,525

                  • 0.00%

                  • 1.78

                  • Franklin Advisers, Inc.

                  •  

                    15,818,550

                  • -0.29%

                  • 1.41

                  • Northern Trust Investments, N.A.

                  •  

                    13,220,783

                  • +1.95%

                  • 1.18

                  • Franklin Mutual Advisers, LLC

                  •  

                    9,837,559

                  • +50.21%

                  • 0.88

                  Company Profile

                  Sector

                  Healthcare

                  Industry

                  Drug Manufacturers – Major

                  Type

                  Slow Growth

                  Style

                  Large Value

                  Eli Lilly and Co was incorporated in 1901 in Indiana. The Company is engaged in drug manufacturing business founded in Indianapolis, Indiana, in 1876. The Company discovers, develops, manufactures, and sells products in two business ...moresegments: human pharmaceutical products and animal health products. Its human pharmaceutical products include: Neuroscience products, Endocrinology products, Oncology products, cardiovascular products and other pharmaceuticals. Neuroscience products include: Cymbalta, Zyprexa, Strattera, Prozac, Symbyax, Amyvid; Endocrinology products: Humalog, Humulin, Byetta, Bydureon, Tradjenta, Jentadueto; Oncology products include: Alimta, Gemzar, Erbitux; Cardiovascular products: Cialis, Effient, ReoPro, Adcirca, Livalo; Other pharmaceutical products include: Vancocin, Ceclor. Anim...moreal Health Products segment includes: Rumensin, a cattle feed additive that improves feed efficiency and growth and also controls and prevents coccidiosis; Tylan, an antibiotic used to control certain diseases in cattle, swine, and poultry; Micotil, Pulmotil, and Pulmotil AC, antibiotics used to treat respiratory disease in cattle, swine, and poultry, respectively; Paylean and Optaflexx, leanness and performance enhancers for swine and cattle, respectively Posilac, a protein supplement to improve milk productivity in dairy cows; Coban, Monteban, and Maxiban, anticoccidial agents for use in poultry; Apralan, an antibiotic used to control enteric infections in calves and swine; Surmax (sold as Maxus™ in some countries), a performance enhancer for swine and poultry. The Company competes with a number of multinational pharmaceutical companies, biotechnology companies, and generic pharmaceutical companies. Its operations are regulated extensively by numerous national, state, and local agencies. The FDA extensively regulates all aspects of manufacturing quality for human pharmaceuticals under its current Good Manufacturing Practices (cGMP) regulations.lessless

                  Key People

                  Dr. John C Lechleiter PhD

                  CEO/Chairman of the Board/Director/President

                  Mr. Derica W. Rice

                  CFO/Executive VP, Divisional

                  Dr. Jan M. Lundberg, PhD

                  Executive VP, Divisional/President, Divisional

                  Mr. Donald A. Zakrowski

                  Chief Accounting Officer/Vice President, Divisional

                  Dr. Karen N. Horn,PhD

                  Director

                  • Eli Lilly and Co

                  • Lilly Corporate Center

                  • Indianapolis, IN 46285

                  • USA.Map

                  • Phone: +1 317 276-2000

                  • Fax: -

                  • lilly.com

                  Incorporated

                  1901

                  Employees

                  37,925

                  Send Feedback

                  We appreciate your input!

                  • I'm having trouble signing into my Microsoft account

                  • I’m having problems with the services stripe (Mail, Facebook, etc.)

                  • There is an issue with my weather information

                  • I see an error in the content

                  • Other

                  Please give an overall site rating: